Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae

被引:36
作者
Adderson, EE
Takahashi, S
Wang, Y
Armstrong, J
Miller, DV
Bohnsack, JF
机构
[1] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA
[2] Joshi Eiyoh Univ, Div Microbiol, Chiyoda Ku, Sakado, Saitama 3500288, Japan
[3] Univ Utah, Dept Pediat, Salt Lake City, UT 84132 USA
[4] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA
关键词
D O I
10.1128/IAI.71.12.6857-6863.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Group B Streptococcus agalactiae bacteria (group B streptococci [GBS]) are the most common cause of serious bacterial infection in newborn infants. The majority of serotype III-related cases of neonatal disease are caused by a genetically related subgroup of bacteria, restriction fragment digest pattern (RDP) type III-3, suggesting that these strains possess unique genes contributing to virulence. We used genomic subtractive hybridization to identify regions of genomic DNA unique to virulent RDP type III-3 GBS strains. Within one of these III-3-specific regions is a 1,506-bp open reading frame, spb1 (surface protein of group B streptococcus 1). A mutant type III GBS strain lacking Spb1 was constructed in virulent RDP type III-3 strain 874391, and the interactions of the wild-type and spb1 isogenic mutant with a variety of epithelial cells important to GBS colonization and infection were compared. While adherence of the spb1 isogenic mutant to A549 respiratory, C2Bbe1 colonic, and HeLa cervical epithelial cells was slightly lower than that of the 874391 strain, invasion of the Spb1(-) mutant was significantly reduced with these cell lines compared to what was seen with 874391. The defect in epithelial invasion was corrected by supplying spb1 in trans. These observations suggest that Spb1 contributes to the pathogenesis of neonatal GBS infection by mediating internalization of virulent serotype III GBS and confirm that understanding of the population structure of bacteria may lead to insights into the pathogenesis of human infections.
引用
收藏
页码:6857 / 6863
页数:7
相关论文
共 38 条
[1]  
Ausubel FM., 1994, Curr. Protoc. Mol. Biol
[2]  
Baker C.J., 1995, INFECT DIS FETUS NEW, V37, P980
[3]  
Baker CJ, 1999, STREPTOCOCCAL INFECTIONS, P222
[4]   CORRELATION OF MATERNAL ANTIBODY DEFICIENCY WITH SUSCEPTIBILITY TO NEONATAL GROUP-B STREPTOCOCCAL INFECTION [J].
BAKER, CJ ;
KASPER, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (14) :753-756
[5]   TRANSMISSION OF GROUP-B STREPTOCOCCI AMONG PARTURIENT WOMEN AND THEIR NEONATES [J].
BAKER, CJ ;
BARRETT, FF .
JOURNAL OF PEDIATRICS, 1973, 83 (06) :919-925
[6]   Identification of a second family of high-molecular-weight adhesion proteins expressed by non-typable Haemophilus influenzae [J].
Barenkamp, SJ ;
StGeme, JW .
MOLECULAR MICROBIOLOGY, 1996, 19 (06) :1215-1223
[7]   CLONING, EXPRESSION, AND DNA-SEQUENCE ANALYSIS OF GENES ENCODING NONTYPABLE HAEMOPHILUS-INFLUENZAE HIGH-MOLECULAR-WEIGHT SURFACE-EXPOSED PROTEINS RELATED TO FILAMENTOUS HEMAGGLUTININ OF BORDETELLA-PERTUSSIS [J].
BARENKAMP, SJ ;
LEININGER, E .
INFECTION AND IMMUNITY, 1992, 60 (04) :1302-1313
[8]   Identification of novel adhesins from group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding [J].
Beckmann, C ;
Waggoner, JD ;
Harris, TO ;
Tamura, GS ;
Rubens, CE .
INFECTION AND IMMUNITY, 2002, 70 (06) :2869-2876
[9]   Long-range mapping of the Streptococcus agalactiae phylogenetic lineage restriction digest pattern type III-3 reveals clustering of virulence genes [J].
Bohnsack, JF ;
Whiting, AA ;
Bradford, RD ;
Van Frank, BK ;
Takahashi, S ;
Adderson, EE .
INFECTION AND IMMUNITY, 2002, 70 (01) :134-139
[10]   Phylogenetic classification of serotype III group B streptococci on the basis of hylB gene analysis and DNA sequences specific to restriction digest pattern type III-3 [J].
Bohnsack, JF ;
Takahashi, S ;
Detrick, SR ;
Pelinka, LR ;
Hammitt, LL ;
Aly, AA ;
Whiting, AA ;
Adderson, EE .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (11) :1694-1697